Combination of YM155, a survivin suppressant, with bendamustine and rituximab: A new combination therapy to treat relapsed/refractory diffuse large B-cell lymphoma

報告日期: 2014/05/09
報告時間: 5:10/6:00
報告學生: 蔡欣玲(以英文報告)
講評老師: 蘇五洲
附件下載: 下載[1407-1396957810-1.pdf]